TX HHS Form 1327. Biosynthetic Growth Hormone Agents Prior Authorization Request (CSHCN)

The TX HHS Form 1327, Biosynthetic Growth Hormone Agents Prior Authorization Request (CSHCN), is a crucial document for healthcare providers to request prior authorization for biosynthetic growth hormone agents for patients with special health care needs. This form helps solve the problem of ensuring that patients receive necessary treatment while also streamlining the review process.

The form requires providers to submit specific information, including patient demographics, medical history, and test results. Key features include questions about the patient's previous growth hormone therapy, growth velocity, and bone age. Providers must also certify that applying the standard review time frame may seriously jeopardize the life or health of the patient. The form is typically completed by healthcare providers who prescribe biosynthetic growth hormone agents for patients with special health care needs.

Some key points to note include:

• The form is used to request prior authorization for biosynthetic growth hormone agents for patients with special health care needs.
• Providers must submit specific information, including patient demographics and medical history.
• The form requires certification that applying the standard review time frame may seriously jeopardize the life or health of the patient.